Thomas R. Vargo

Also affiliated with Panthera Corporation, Discovery Laboratories (United States)

MedicineMaterials ScienceBiochemistry, Genetics and Molecular BiologyChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Self-Immolative Carbamate Linkers for CD19-Budesonide Antibody–Drug Conjugates”.

Self-Immolative Carbamate Linkers for CD19-Budesonide Antibody–Drug Conjugates

Bioconjugate Chemistry(2023)10.1021/acs.bioconjchem.3c00354

N/A

0.406DataRank · unranked

14 citations

Adrian D. Hobson, Michael J. McPherson, Theresa A. Dunstan, Thomas R. Vargo, Martin E. Hayes +8 more

Self-Immolative Carbamate Linkers for CD19-Budesonide Antibody-Drug Conjugates

ChemRxiv(2023)10.26434/chemrxiv-2023-7lk43

N/A

0DataRank · unranked

1 citations

Adrian D. Hobson, Michael J. McPherson, T Don J. Dunstan, Thomas R. Vargo, Martin A. Hayes +8 more

Discovery of potent SARS-CoV-2 nsp3 macrodomain inhibitors uncovers lack of translation to cellular antiviral response

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.08.19.608619

N/A

0DataRank · unranked

8 citations

Isabelle Amick, J.C. Aschenbrenner, Haim Barr, Jared Benjamin, Alexander Brandis +28 more